S
Shanghai OPM Biosciences Co Ltd
SSE:688293
Shanghai OPM Biosciences Co Ltd
SSE:688293
Price:
52.26
CNY
0.6%
Market Cap:
¥6.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shanghai OPM Biosciences Co Ltd
SSE:688293
|
CN |
|
G
|
General Dynamics Corp
XETRA:GDX
|
US |
|
C
|
CPM Group Ltd
HKEX:1932
|
HK |
Income Statement
Earnings Waterfall
Shanghai OPM Biosciences Co Ltd
Shanghai OPM Biosciences Co Ltd
Income Statement
Shanghai OPM Biosciences Co Ltd
Shanghai OPM Biosciences Co Ltd
Currency: CNY
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
5
|
5
|
5
|
5
|
0
|
4
|
3
|
3
|
4
|
3
|
3
|
3
|
0
|
|
| Revenue |
277
N/A
|
285
+3%
|
294
+3%
|
290
-2%
|
269
-7%
|
243
-10%
|
243
+0%
|
255
+5%
|
265
+4%
|
287
+8%
|
297
+3%
|
301
+1%
|
331
+10%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
(101)
|
(105)
|
(106)
|
(105)
|
(105)
|
(103)
|
(100)
|
(105)
|
(112)
|
(123)
|
(139)
|
(148)
|
(162)
|
|
| Gross Profit |
176
N/A
|
180
+2%
|
188
+5%
|
185
-2%
|
164
-11%
|
140
-15%
|
143
+2%
|
150
+5%
|
153
+2%
|
165
+7%
|
158
-4%
|
153
-3%
|
169
+11%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(75)
|
(79)
|
(89)
|
(95)
|
(101)
|
(106)
|
(116)
|
(127)
|
(137)
|
(141)
|
(147)
|
(154)
|
(151)
|
|
| Selling, General & Administrative |
(53)
|
(56)
|
(59)
|
(68)
|
(71)
|
(71)
|
(74)
|
(94)
|
(108)
|
(116)
|
(104)
|
(107)
|
(98)
|
|
| Research & Development |
(21)
|
(28)
|
(26)
|
(38)
|
(40)
|
(42)
|
(34)
|
(41)
|
(38)
|
(34)
|
(28)
|
(39)
|
(43)
|
|
| Depreciation & Amortization |
0
|
0
|
(14)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
|
| Other Operating Expenses |
(1)
|
5
|
10
|
10
|
10
|
6
|
8
|
8
|
8
|
9
|
2
|
(8)
|
(10)
|
|
| Operating Income |
101
N/A
|
101
0%
|
99
-2%
|
90
-9%
|
63
-30%
|
34
-47%
|
26
-22%
|
23
-12%
|
16
-32%
|
24
+49%
|
11
-52%
|
(1)
N/A
|
18
N/A
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
4
|
10
|
17
|
24
|
36
|
37
|
35
|
34
|
33
|
29
|
35
|
37
|
37
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
6
|
2
|
4
|
3
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
111
N/A
|
114
+2%
|
119
+5%
|
117
-2%
|
100
-15%
|
71
-29%
|
62
-13%
|
57
-7%
|
49
-15%
|
52
+7%
|
36
-30%
|
36
-2%
|
55
+55%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
(17)
|
(16)
|
(14)
|
(13)
|
(11)
|
(6)
|
(8)
|
(9)
|
(9)
|
(15)
|
(16)
|
(20)
|
(22)
|
|
| Income from Continuing Operations |
95
|
97
|
105
|
104
|
90
|
65
|
53
|
49
|
39
|
37
|
20
|
15
|
34
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Net Income (Common) |
95
N/A
|
97
+3%
|
105
+8%
|
104
-1%
|
90
-14%
|
65
-27%
|
54
-17%
|
49
-9%
|
40
-18%
|
38
-5%
|
21
-45%
|
16
-23%
|
34
+113%
|
|
| EPS (Diluted) |
0.82
N/A
|
0.84
+2%
|
0.92
+10%
|
0.9
-2%
|
0.78
-13%
|
0.57
-27%
|
0.47
-18%
|
0.43
-9%
|
0.35
-19%
|
0.33
-6%
|
0.18
-45%
|
0.14
-22%
|
0.3
+114%
|
|
Switch to:
Switch to:
See Also
Discover More
